Advisor Resource Council Takes $258,000 Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Advisor Resource Council acquired a new stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,953 shares of the biopharmaceutical company’s stock, valued at approximately $258,000. Several other institutional investors and […]
